Ultrasound and Imaging in Ophthalmology

When a dense cataract, vitreous hemorrhage, or corneal opacity blocks the view of the retina, the clinician faces a straightforward problem: the structures that matter most are the ones that cannot be seen. Ophthalmic ultrasound and advanced imaging technologies solve that problem — and a growing number of others — by rendering the eye's internal anatomy in ways that direct examination simply cannot match. The global ophthalmic ultrasound market was valued at approximately $870 million in 2022, reflecting the central role these instruments play in clinical decision-making across subspecialties (National Institutes of Health / NLM).

Ophthalmic Ultrasound: Principles and Modes

Ophthalmic ultrasound relies on high-frequency sound waves — typically between 8 MHz and 50 MHz — directed into ocular tissues. The returning echoes are processed into images that reveal structural detail invisible to conventional ophthalmoscopy.

A-Scan (Amplitude Scan)

A-scan ultrasonography produces a one-dimensional waveform representing tissue interfaces along a single axis. Its most common clinical application is axial length measurement before cataract surgery, where accuracy to within ±0.1 mm can shift the postoperative refractive outcome by roughly 0.27 diopters. A-scan biometry remains the fallback when optical biometry instruments cannot penetrate opaque media. Standardized A-scan echography, refined by Karl Ossoinig at the University of Iowa in the 1970s, also allows tissue characterization — differentiating melanoma from metastatic lesions based on internal reflectivity patterns (University of Iowa Health Care).

B-Scan (Brightness Scan)

B-scan ultrasonography generates a two-dimensional, cross-sectional grayscale image of the globe and orbit. Operating at 10 MHz in standard instruments, it is indispensable for evaluating retinal detachments, vitreous opacities, intraocular tumors, and posterior scleritis. A retinal detachment appears as a bright, continuous membrane attached to the optic disc, while a posterior vitreous detachment shows a mobile, less reflective membrane free of the disc — a distinction that directly alters surgical planning.

Ultrasound Biomicroscopy (UBM)

UBM uses frequencies between 35 MHz and 50 MHz, achieving axial resolution of approximately 25 micrometers at the cost of reduced penetration depth (roughly 4–5 mm). This makes it ideal for anterior segment evaluation: angle-closure mechanisms, ciliary body tumors, plateau iris syndrome, and the position of intraocular lens haptics. The technology provides detail that even anterior segment optical coherence tomography cannot replicate behind the iris pigment epithelium.

Optical Coherence Tomography (OCT)

Since its introduction in 1991 by a team at MIT led by James Fujimoto and David Huang, OCT has arguably transformed ophthalmology more than any other single imaging modality. It uses low-coherence interferometry — light rather than sound — to produce cross-sectional images of the retina with axial resolution approaching 3–5 micrometers in spectral-domain systems.

Spectral-Domain and Swept-Source OCT

Spectral-domain OCT (SD-OCT) captures roughly 27,000 to 100,000 A-scans per second, depending on the platform. Swept-source OCT (SS-OCT) operates at longer wavelengths (around 1,050 nm) and achieves speeds exceeding 200,000 A-scans per second, improving penetration through the retinal pigment epithelium into the choroid. This deeper imaging has enabled the identification of pachychoroid spectrum disorders, a category that was essentially unrecognized before enhanced depth imaging became routine.

OCT Angiography (OCTA)

OCTA detects motion contrast — the movement of red blood cells through vasculature — without injecting fluorescein dye. It produces three-dimensional maps of retinal and choroidal blood flow, revealing capillary nonperfusion zones in diabetic retinopathy and delineating choroidal neovascular membranes in age-related macular degeneration. The National Eye Institute estimates that diabetic retinopathy affects approximately 7.7 million Americans, making noninvasive vascular imaging of the retina a significant public health tool (National Eye Institute).

Fundus Photography and Fluorescein Angiography

Conventional fundus photography captures a two-dimensional color image of the posterior pole. Ultra-widefield systems, such as the Optos platform, image up to 200 degrees of the retina in a single capture — compared to roughly 30–50 degrees for a standard fundus camera. Fluorescein angiography (FA) adds temporal information: the transit of sodium fluorescein dye through retinal vessels reveals leakage, ischemia, and neovascularization in real time. FA remains the reference standard for grading diabetic macular edema and identifying retinal vein occlusion subtypes, even as OCTA handles a growing share of the diagnostic workload.

Emerging Technologies

Adaptive optics scanning laser ophthalmoscopy (AO-SLO) resolves individual photoreceptor cells and has demonstrated cone mosaic disruption in conditions like retinitis pigmentosa and hydroxychloroquine toxicity. Artificial intelligence–assisted image analysis, including FDA-cleared autonomous screening systems such as IDx-DR (now Digital Diagnostics), can detect more-than-mild diabetic retinopathy with 87.2% sensitivity and 90.7% specificity, as demonstrated in a pivotal clinical trial published in npj Digital Medicine (FDA).

FAQ

When is B-scan ultrasound preferred over OCT?

B-scan ultrasound is preferred when opaque media — such as a dense vitreous hemorrhage, mature cataract, or corneal scar — prevent light-based imaging from reaching the retina. It is also the primary tool for evaluating orbital pathology behind the globe, where OCT cannot penetrate.

Does OCT angiography replace fluorescein angiography?

Not entirely. OCTA excels at structural vascular mapping but does not capture leakage dynamics. Fluorescein angiography remains necessary for assessing active vascular leakage, particularly in uveitic conditions and certain neovascular membranes where treatment timing depends on leakage patterns.

How accurate is ultrasound for diagnosing intraocular tumors?

Standardized A-scan echography combined with B-scan imaging achieves diagnostic accuracy exceeding 95% for choroidal melanoma, based on established criteria including low-to-medium internal reflectivity, acoustic hollowing, and choroidal excavation. Collaborative Ocular Melanoma Study (COMS) data validated ultrasound-based diagnosis against histopathologic findings (National Cancer Institute).

References

• National Eye Institute — Diabetic Retinopathy
• University of Iowa Health Care — Ophthalmic Ultrasonography
• FDA — AI-Based Device for Diabetic Retinopathy Detection
• National Cancer Institute — Eye Cancer
• National Library of Medicine / PubMed

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)